Apixaban in Comparison to Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Observational Studies.

Conclusion: Apixaban is superior to warfarin in terms of safety, but no difference in efficacy is noted. The choice of anticoagulation should be individualized based on the risk factor profile of the patient. PMID: 31360545 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31360545?dopt=Abstract

Source: Cardiology Research and Practice - August 1, 2019 Category: Cardiology Authors: Siddiqui MU, Scalzitti D, Naeem Z Tags: Cardiol Res Pract Source Type: research